299 related articles for article (PubMed ID: 33231813)
1. Identification of Systems Level Molecular Signatures from Glioblastoma Multiforme Derived Extracellular Vesicles.
Roy N; Gaikwad M; Bhattacharrya DK; Barah P
J Mol Neurosci; 2021 Jun; 71(6):1156-1167. PubMed ID: 33231813
[TBL] [Abstract][Full Text] [Related]
2. Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis.
Chen X; Pan Y; Yan M; Bao G; Sun X
Mol Med Rep; 2020 Aug; 22(2):859-869. PubMed ID: 32467990
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
[TBL] [Abstract][Full Text] [Related]
4. Identification of Crucial Candidate Genes and Pathways in Glioblastoma Multiform by Bioinformatics Analysis.
Alshabi AM; Vastrad B; Shaikh IA; Vastrad C
Biomolecules; 2019 May; 9(5):. PubMed ID: 31137733
[TBL] [Abstract][Full Text] [Related]
5. Identification of hub genes and regulatory factors of glioblastoma multiforme subgroups by RNA-seq data analysis.
Li Y; Min W; Li M; Han G; Dai D; Zhang L; Chen X; Wang X; Zhang Y; Yue Z; Liu J
Int J Mol Med; 2016 Oct; 38(4):1170-8. PubMed ID: 27572852
[TBL] [Abstract][Full Text] [Related]
6. Non-negative matrix factorization and differential expression analyses identify hub genes linked to progression and prognosis of glioblastoma multiforme.
Akçay S; Güven E; Afzal M; Kazmi I
Gene; 2022 May; 824():146395. PubMed ID: 35283227
[TBL] [Abstract][Full Text] [Related]
7. Multi-omics analysis predicts fibronectin 1 as a prognostic biomarker in glioblastoma multiforme.
Kabir F; Apu MNH
Genomics; 2022 May; 114(3):110378. PubMed ID: 35513291
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatics and machine learning methodologies to identify the effects of central nervous system disorders on glioblastoma progression.
Rahman MH; Rana HK; Peng S; Hu X; Chen C; Quinn JMW; Moni MA
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33406529
[TBL] [Abstract][Full Text] [Related]
9. Association between SNAP25 and human glioblastoma multiform: a comprehensive bioinformatic analysis.
Yu C; Yin J; Wang X; Chen L; Wei Y; Lu C; You Y
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32412599
[TBL] [Abstract][Full Text] [Related]
10. PBK as a Potential Biomarker Associated with Prognosis of Glioblastoma.
Dong C; Fan W; Fang S
J Mol Neurosci; 2020 Jan; 70(1):56-64. PubMed ID: 31617063
[TBL] [Abstract][Full Text] [Related]
11. Integration of RNA-Seq and proteomics data identifies glioblastoma multiforme surfaceome signature.
Syafruddin SE; Nazarie WFWM; Moidu NA; Soon BH; Mohtar MA
BMC Cancer; 2021 Jul; 21(1):850. PubMed ID: 34301218
[TBL] [Abstract][Full Text] [Related]
12. Gene and microRNA Signatures Are Associated with the Development and Survival of Glioblastoma Patients.
Yang Q; Wang R; Wei B; Peng C; Wang L; Hu G; Kong D; Du C
DNA Cell Biol; 2019 Jul; 38(7):688-699. PubMed ID: 31188028
[TBL] [Abstract][Full Text] [Related]
13. Identification of key genes involved in the recurrence of glioblastoma multiforme using weighted gene co-expression network analysis and differential expression analysis.
Ren P; Wang J; Li L; Lin X; Wu G; Chen J; Zeng Z; Zhang H
Bioengineered; 2021 Dec; 12(1):3188-3200. PubMed ID: 34238116
[TBL] [Abstract][Full Text] [Related]
14. Identification of biomarkers associated with extracellular vesicles based on an integrative pan-cancer bioinformatics analysis.
Wang Q; Yu C
Med Oncol; 2020 Aug; 37(9):79. PubMed ID: 32749536
[TBL] [Abstract][Full Text] [Related]
15. Computational analysis and verification of molecular genetic targets for glioblastoma.
Xue L; Liu H; Chen Y; Wei L; Hong J
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32469390
[TBL] [Abstract][Full Text] [Related]
16. Identification of Hub Genes and Key Pathways Associated with Anti-
Arya KR; Bharath Chand RP; Abhinand CS; Nair AS; Oommen OV; Sudhakaran PR
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33803224
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive Analysis of CD163 as a Prognostic Biomarker and Associated with Immune Infiltration in Glioblastoma Multiforme.
Li H; Wang D; Yi B; Cai H; Xi Z; Lou X; Li Z
Biomed Res Int; 2021; 2021():8357585. PubMed ID: 34395626
[TBL] [Abstract][Full Text] [Related]
18. Integrative analysis of DNA methylation and gene expression profiles to identify biomarkers of glioblastoma.
Alivand MR; Najafi S; Esmaeili S; Rahmanpour D; Zhaleh H; Rahmati Y
Cancer Genet; 2021 Nov; 258-259():135-150. PubMed ID: 34773808
[TBL] [Abstract][Full Text] [Related]
19. Identification of Prognostic Biomarkers for Glioblastoma Based on Transcriptome and Proteome Association Analysis.
Wang J; Yan S; Chen X; Wang A; Han Z; Liu B; Shen H
Technol Cancer Res Treat; 2022; 21():15330338211035270. PubMed ID: 35538679
[TBL] [Abstract][Full Text] [Related]
20. Short non-coding RNA sequencing of glioblastoma extracellular vesicles.
de Mooij T; Peterson TE; Evans J; McCutcheon B; Parney IF
J Neurooncol; 2020 Jan; 146(2):253-263. PubMed ID: 31912278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
